C.A.D. Sousa et al. / Tetrahedron xxx (2013) 1e10
9
125.0 (Cpara), 75.0 (C18PM), 70.5 (C3), 69.0 (C1), 50.4 (C28PM), 47.2
(C4), 45.0 (C7), 41.6 (CH2), 39.6 (C88-PM), 34.6 (CH2), 31.2 (C58PM),
26.5 (CH2), 24.7 and 28.1 (2ꢁ 8-CH3-8PM), 21.8 (5-CH3-8PM); 15N
(2s, 6H, 8-(CH3)2-8PnM), 0.77e0.99 (m, 2H8-PnM), 0.82 (d, J¼6.6 Hz,
3H, 5-CH3-8PnM).
NMR (40 MHz, CDCl3):
d
¼148.
4.6.4.7. Compound 11b. 1H NMR (400 MHz, CDCl3):
d¼7.26e7.35
(m, 5HPh), 7.17e7.24 (m, 1HPh), 6.05e6.10 (m, 1H, H8), 5.55 (ddd,
J¼5.6, 4.4, 2.1 Hz,1H, H7), 5.41e5.45 (m,1H, H1), 5.32e5.50 (br s,1H,
NH), 5.05e5.08 (s,1H, H18-PnM), 3.88 (d, J¼7.9 Hz,1H, H4), 3.33e3.41
(m,1H, H5), 2.38e2.47 (m,1H, H6syn), 2.12 (dquint, J¼18.1, 2.3 Hz,1H,
H6anti),1.88 (ddd, J¼14.4, 6.0, 3.6Hz,1H8-PnM),1.72e1.82 (m,1H8-PnM),
1.46e1.70 (m, 4H8-PnM), 1.33 and 1.34 (2s, 6H, 8-(CH3)2-8PnM),
0.96e1.10 (m, 2H8-PnM), 0.85 (d, J¼6.5 Hz, 3H, 5-CH3-8PnM); 13C NMR
4.6.4.2. Compound 11a. 1H NMR (400 MHz, CDCl3):
d
¼7.27e7.37
(m, 5HPh), 7.14e7.21 (m, 1HPh), 6.00e6.05 (m, 1H, H8), 5.58 (ddd,
J¼5.6, 4.3, 2.1 Hz,1H, H7), 5.29 (d, J¼6.8 Hz,1H, H1), 5.05e5.45 (br s,
1H, NH), 4.89 (dt, J¼10.8, 4.4 Hz, 1H, H18PM), 3.09 (d, J¼8.1 Hz, 1H,
H4), 2.95e3.30 (m, 1H, H5), 2.31e2.40 (m, 1H, H6syn), 2.05e2.13 (m,
1H8-PM), 2.01 (dquint, J¼18.2, 2.3 Hz, 1H, H6anti), 1.86e1.94 (m, 1H8-
PM), 1.81 (dq, J¼13.4, 3.4 Hz, 1H8-PM), 1.67e1.74 (m, 1H8-PM),
1.43e1.55 (m, 2H8-PM), 1.32 and 1.23 (2s, 6H, 8-(CH3)2-8PM),
1.13e1.19 (m, 1H8-PM), 0.97e1.03 (m, 1H8-PM), 0.91 (d, J¼6.5 Hz, 3H,
(100 MHz, CDCl3):
d¼168.5 (COO), 148.9 (8-Cipso), 137.6 (C8), 128.1
(2ꢁ CPh) and 126.0 (2ꢁ CPh), 126.0 (C7), 125.8 (Cpara), 92.0 (C1), 72.4
(C18-PnM), 67.4 (C4), 51.0 (C28-PnM), 45.8 (C5), 39.9 (CH2), 39.9
(C88-PnM), 35.2 (CH2), 34.2 (C6), 27.0 (2ꢁ 8-CH3-8PnM), 26.0, 22.3
5-CH3-8PM); 13C NMR (100 MHz, CDCl3):
d
¼169.7 (COO), 152.4
(8-Cipso), 138.4 (C8), 128.9 (2ꢁ CPh) and 129.0 (2ꢁ CPh), 126.2 (C7),
126.1 (Cpara), 92.7 (C1), 76.2 (C18PM), 66.7 (C4), 51.2 (C28PM), 46.3
(C5), 42.3 (CH2), 40.4 (C88PM), 35.4 (C6), 35.4 (CH2), 32.2, 29.6, 27.3
(CH2), 21.9 (5-CH3-8PnM); 15N NMR (40 MHz, CDCl3):
d
¼141; ESI-TOF:
calculated for [C23H31NO3þH]þ (MþHþ) 370.23, found 370.2377.
(CH2), 24.9, 22.7; 15N NMR (40 MHz, CDCl3):
d
¼142; ESI-TOF: cal-
4.6.4.8. Compound 11b0. 1H NMR (400 MHz, CDCl3):
22
culated for [C23H31NO3þH]þ (MþHþ) 370.23, found 370.2377, [
ꢀ19.2 (c 0.32, CHCl3).
a
]
d
¼7.26e7.35 (m, 5HPh), 7.17e7.24 (m, 1HPh), 6.10e6.14 (m, 1H, H8),
D
5.67 (ddd, J¼5.6, 4.4, 2.1 Hz, 1H, H7), 5.44e5.48 (m, 1H, H1),
5.32e5.50 (br s, 1H, NH), 5.03e5.06 (s, 1H, H18-PnM), 3.98 (d,
J¼7.8 Hz, 1H, H4), 3.41e3.49 (m, 1H, H5), 2.49e2.58 (m, 1H, H6syn),
2.26 (dquint, J¼18.1, 2.3 Hz, 1H, H6anti), 2.00 (ddd, J¼14.4, 6.0,
3.6 Hz, 1H8-PnM), 1.72e1.82 (m, 1H8-PnM), 1.46e1.70 (m, 4H8-PnM),
1.33 and 1.34 (2s, 6H, 8-(CH3)2-8PnM), 0.96e1.10 (m, 2H8-PnM), 0.84
4.6.4.3. Compound 11a0. 1H NMR (400 MHz, CDCl3):
¼7.27e7.37 (m, 5HPh), 7.14e7.21 (m, 1HPh), 6.08e6.12 (m, 1H, H8),
d
5.63 (ddd, J¼5.6, 4.3, 2.1 Hz, 1H, H7), 5.37 (d, J¼6.6 Hz, 1H, H1),
5.05e5.45 (br s,1H, NH), 4.86 (dt, J¼10.8, 4.3 Hz,1H, H18PM), 3.69 (d,
J¼7.7 Hz, 1H, H4), 3.16e3.23 (m, 1H, H5), 2.40e2.49 (m, 1H, H6syn),
2.24e2.31 (m, 1H, H6anti), 0.93e2.14 (m, 8H8-PM), 1.37 and 1.26 (2s,
6H, 8-(CH3)2-8PM), 0.88 (d, J¼6.5 Hz, 3H, 5-CH3-8PM); 13C NMR
(d, J¼6.5 Hz, 3H, 5-CH3-8PnM); 13C NMR (100 MHz, CDCl3):
¼170.0
d
(COO), 149.5 (8-Cipso), 137.7 (C8), 128.0 (2ꢁ CPh) and 125.8 (2ꢁ CPh),
125.8 (C7), 125.8 (Cpara), 92.0 (C1), 73.5 (C18-PnM), 66.7 (C4), 50.9
(C28-PnM), 45.8 (C5), 39.9 (C88-PnM), 39.8 (CH2), 35.3 (CH2), 34.6 (C6),
26.9 (2ꢁ 8-CH3-8PnM), 25.7, 22.3 (CH2), 21.9; 15N NMR (40 MHz,
(100 MHz, CDCl3):
d
¼169.6 (COO), 152.0 (8-Cipso), 138.6 (C8), 129.3
(2ꢁ CPh) and 128.8 (2ꢁ CPh), 126.7 (C7), 126.3 (Cpara), 77.9 (C1), 73.2
(C18PM), 69.3 (C4), 50.8 (C28PM), 46.6 (C5), 42.5 (CH2), 41.0 (C88PM),
39.1 (CH2), 35.3 (CH2), 32.3, 29.1, 28.0 (CH2), 25.5, 22.6; 15N NMR
CDCl3):
d
¼141.
(40 MHz, CDCl3):
d¼142.
Acknowledgements
ˇ
4.6.4.4. Compound 9b. 1H NMR (400 MHz, CDCl3):
d
¼7.29e7.34
~
Thanks are due to Fundac¸ ao para a Ciencia e Tecnologia (FCT) for
financial support through the re-equipment program REDE/1517/
RMN/2005 and CONC-REEQ/275/QUI. C.A.D.S. acknowledges FCT
for the award of the Research Grants SFRH/BD/31526/2006 and
SFRH/BPD/80100/2011 and C.F.R.A.C.L. for the grant SFRH/BD/
29394/2006.
(m, 5HPh), 7.16e7.23 (m, 1HPh), 6.64e6.67 (m, 1H, H5), 6.31 (dd,
J¼5.6, 2.0 Hz, 1H, 6-H), 4.95e5.10 (1H, H18-PnM), 4.31 (s, 1H, H1),
3.19 (s, 1H, H4), 2.77 (d, J¼2.1 Hz, 1H, H3), 1.52e1.96 (m,
5H8-PnMþH7synþH7anti), 1.45e1.50 (m, 1H8-PnM), 1.33 and 1.38 (2s,
6H, 8-(CH3)2-8PnM), 0.87e1.52 (m, 2H8-PnM), 0.83e0.86 (3H,
5-CH3-8PnM); 13C NMR (100 MHz, CDCl3):
d
¼171.7 (COO), 149.4
(8-Cipso), 138.1 (C5), 133.2 (C6), 127.8e128.1 (2ꢁ CPh), 125.5e126.0
(3ꢁ CPh), 72.1 (C18-PnM), 70.5 (C3), 68.7 (C1), 51.2 (C28PnM), 46.9
(C4), 45.2 (C7), 39.6e40.0 (C88-PnMþCH2), 35.3 (CH2), 26.0e27.1
(C58-PnMþ2ꢁ 8-CH3-8PnM), 22.4 (CH2), 22.0 (5-CH3-8PnM); 15N NMR
Supplementary data
1H NMR and 13C NMR spectra of all compounds plus NOE NMR
data for 8-PMGO, 8-PnMGO and 8-PinMGO, as well as crystallo-
graphic data for 8-PnMGO and detailed computational results can
be found. Supplementary data related to this article can be found
include MOL files and InChiKeys of the most important compounds
described in this article.
(40 MHz, CDCl3):
d¼150.
4.6.4.5. Compound 9b0. 1H NMR (400 MHz, CDCl3):
d¼7.29e7.34
(m, 5HPh), 7.16e7.23 (m, 1HPh), 6.61e6.64 (m, 1H, H5), 6.31 (dd,
J¼5.6, 2.0 Hz, 1H, H6), 4.99 (sl, 1H, H18-PnM), 4.31 (s, 1H, H1), 3.05
(s, 1H, H4), 2.78 (d, J¼2.1 Hz, 1H, H3), 1.52e1.96 (m,
5H8-PnMþH7synþH7anti), 1.45e1.50 (m, 1H8-PnM), 1.36 and 1.38 (2s,
6H, 8-(CH3)2-8PnM), 0.87e1.52 (m, 2H8-PnM), 0.84 (d, J¼6.5 Hz, 3H,
References and notes
5-CH3-8PnM); 13C NMR (100 MHz, CDCl3):
d
¼171.5 (COO), 149.3
1. (a) Corey, E. J.; Becker, K. B.; Varma, R. K. J. Am. Chem. Soc.1972, 94, 8616e8618; (b)
Corey, E. J.; Ensley, H. E. J. Am. Chem. Soc. 1975, 97, 6908e6909; (c) Quinkert, G.;
Schmalz, H.; Dzierzynski, E. M.; Durner, G.; Bats, J. W. Angew. Chem., Int. Ed. Engl.
1986, 25, 992e993; (d) Corey, E. J. Angew. Chem., Int. Ed. 2002, 41, 1650e1667.
2. Whitesell, J. K.; Liu, C. L.; Buchanan, C. M.; Chen, H.-H.; Minton, M. A. J. Org.
Chem. 1986, 51, 551e553.
(8-Cipso), 138.0 (C5), 133.1 (C6), 128.0 (2ꢁ CPh), 126.0 (2ꢁ CPh), 125.0
(Cpara), 72.6 (C18-PnM), 70.8 (C3), 69.0 (C1), 51.3 (C28-PnM), 47.2 (C4),
45.3 (C7), 39.8 (C88-PnM), 39.7 (CH2), 35.3 (CH2), 26.0e27.1
(C58-PnMþ2ꢁ 8-CH3-8PnM), 22.4 (CH2), 22.1 (5-CH3-8PnM); 15N NMR
€
3. (a) Halterman, R. L.; Vollhard, K. P. C. Organometallics 1988, 7, 883e892; (b)
Blanco, J. M.; Caamano, O.; Fernandez, F.; García-Mera, X.; Lopez, C.; Rodríguez,
(40 MHz, CDCl3):
d¼150.
~
ꢀ
ꢀ
G.; Rodríguez-Borges, J. E.; Rodríguez-Hergueta. Tetrahedron Lett. 1998, 39,
5663e5666; (c) Fernandez, F.; García-Mera, X.; Lopez, C.; Rodríguez, G.;
Rodríguez-Borges, J. E. Tetrahedron: Asymmetry 2000, 11, 4805e4815; (d)
4.6.4.6. Compound 10b. 1H NMR (400 MHz, CDCl3):
¼7.27e7.35 (m, 5HPh), 7.17e7.24 (m, 1HPh), 6.30 (dd, J¼5.5, 3.3 Hz,
ꢀ
ꢀ
d
~
ꢀ
Caamano, O.; Fernandez, F.; García-Mera, X.; Rodríguez-Borges, J. E. Tetrahedron
1H, H5), 6.21 (dd, J¼5.5, 2.5 Hz,1H, H6), 5.08 (br s, 1H, H18-PnM), 4.16
(s, 1H, H1), 3.67 (d, J¼3.3 Hz, 1H, H3), 3.28 (s, 1H, H4), 2.25 (d,
J¼8.7 Hz, 1H, H7syn), 1.52e1.88 (m, 6H8-PnMþH7anti), 1.33 and 1.34
ꢀ
Lett. 2000, 41, 4123e4125; (e) Fernandez, F.; García-Mera, X.; Rodríguez-Borges,
J. E.; Blanco, J. M. Tetrahedron Lett. 2001, 42, 5239e5240; (f) Fernandez, F.;
ꢀ
García-Mera, X.; Vale, M. L. C.; Rodríguez-Borges, J. E. Synlett 2005, 319e321;